
May 19, 2023
RegMed Investors’ (RMi) pre-open: who and what can be trusted re debt ceiling
May 18, 2023
RegMed Investors’ (RMi) closing bell: too many factors are calling the ball on share pricing
May 18, 2023
RegMed Investors’ (RMi) pre-open: If you're buying into strength, you might be jumping onto a sinking ship
May 16, 2023
RegMed Investors’ (RMi) closing bell: biotech, cell and gene therapy sector sinks
May 16, 2023
RegMed Investors’ (RMi) pre-open: are we owning the unownable?
May 15, 2023
RegMed Investors’ (RMi) closing bell: a waiting game
May 15, 2023
UniQure NV (QURE) to sell royalty interest in blood disorder therapy for up to $400 M
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors